Literature DB >> 35495842

A study of electrocardiographic and 2D echocardiographic changes in type 2 diabetes mellitus patients without cardiovascular symptoms.

Vasudha V Sardesai1, Hemant T Kokane1, Souradip Mukherjee1, Shashikala A Sangle1.   

Abstract

Context: Cardiovascular diseases in diabetic patients are mostly asymptomatic due to autonomic neuropathy. Many patients with left ventricular dysfunction remain undiagnosed and untreated until advance disease causes disability. This delay could be avoided if screening techniques are used to identify left ventricular dysfunction in its preclinical phase. Aims: This study was undertaken to find out the incidence of electrocardiographic (ECG) and 2D echocardiographic (2 D Echo) abnormalities in diabetic patients without cardiovascular symptoms. The correlation of control of diabetes with these abnormalities was also studied. Settings and Design: A hospital-based, cross-sectional observational study. Methods and Material: Type 2 diabetic patients (outpatient and indoor) without cardiovascular symptoms like palpitations, chest pain, syncope, and breathlessness were included in the study. Their ECG and 2D Echo findings were noted and correlated with their blood sugar levels. Statistical Analysis Used: Chi-square test.
Results: Type 2 diabetic patients without cardiovascular symptoms had significant abnormal findings on ECG and 2D Echo. Control of postprandial blood sugar level was of primary importance to prevent cardiovascular abnormalities. Conclusions: Type 2 diabetics without cardiovascular symptoms must be screened for cardiovascular abnormalities so that early interventions can be done to prevent further progression to symptomatic cardiovascular abnormalities. There is a significant number of people having normal ECG but abnormal 2D Echo and vice versa, so not only ECG but also 2D Echo should be done to predict cardiovascular risk in type 2 diabetic patients without cardiovascular symptoms. Copyright:
© 2022 Journal of Family Medicine and Primary Care.

Entities:  

Keywords:  Asymptomatic diabetics; echocardiogram; electrocardiogram

Year:  2022        PMID: 35495842      PMCID: PMC9051686          DOI: 10.4103/jfmpc.jfmpc_1195_21

Source DB:  PubMed          Journal:  J Family Med Prim Care        ISSN: 2249-4863


Introduction

Diabetes Mellitus (DM) is a chronic disease caused by inherited or acquired deficiency in the production of insulin or by insulin resistance.[1] DM has attained epidemic proportions in India and high proportion of patients seen by primary care physicians are diabetic. India has an estimated 77 million people with diabetes and after China, it is the second most affected country in the world.[2] The leading cause of morbidity and mortality in patients with type 2 DM is cardiovascular disease,[3] and these patients have a high risk of coronary artery disease that is many times silent.[4] Premature atherosclerosis due to endothelial dysfunction, vascular effects of advanced glycation products, untoward effects of circulating free fatty acids and increased systemic inflammation is seen with diabetes.[4] This results into coronary artery disease, heart failure or arrhythmias due to diabetic cardiomyopathy. Most diabetic cardiovascular diseases are asymptomatic (silent or painless ischemia) due to autonomic neuropathy. Many patients with left ventricular dysfunction remain undiagnosed and untreated until advanced disease causes disability or death. This is the biggest challenge for primary physicians. This delay can be avoided if screening techniques are used to identify left ventricular dysfunction in its preclinical phase.[4] Hence, a study was undertaken to find out the incidence of electrocardiographic (ECG) and 2 dimensional echocardiographic (2D echo) abnormalities in diabetic patients without cardiovascular symptoms. The correlation of control of diabetes with these abnormalities was also studied.

Subjects and Methods

It was a hospital-based, cross-sectional observational study in a tertiary care center and teaching institute. Institutional ethics committee clearance was taken (ref. 1218233-233). One hundred and thirty adult patients of type 2 DM coming to tertiary care hospital, either for out-patient advice or indoor treatment and who were willing to participate in the study, were included. These patients were without cardiovascular symptoms like palpitations, chest pain, blackout, or breathlessness. Their ECG and 2D echo findings were noted and correlated with their blood sugar levels. Patients with any cardiovascular symptom or with previous diagnosis of cardiovascular disease were excluded from the study.

Results

In the present study, a total of 130 diabetic patients without cardiovascular symptoms were studied. The mean age of patients was 56.3 ± 8.60 and maximum number of cases (52.3%) were in the age group between 51 and 60 years of age. Males were 58.5%, whereas females were 41.5%. Patients with duration of diabetes more than 5 years were 39.2%. Epidemiological characteristics such as sex, age, and duration of diabetes showed no correlation with ECG findings. (p = 0.215 with age), (p = 0.215 with sex), (p = 0.430 with duration of diabetes). Characteristics such as sex and duration of diabetes showed no correlation with 2D Echo findings. (p = 0.724 and P = 0.067, respectively), but there was significant correlation between abnormal 2D Echo findings and age (p = 0.01). 2D Echo abnormalities increase with increasing age. ECG abnormalities showed significant correlation with random and postprandial blood sugar, but not with fasting blood sugar [Table 1]. 2 D Echo abnormalities showed significant correlation with random, fasting, and postprandial blood sugar levels [Table 2].
Table 1

Correlation of ECG findings with blood sugar levels

Blood sugarValueECGTotal P

NormalAbnormal
RandomNormal3222540.021*
Abnormal294776
FastingNormal3328610.159
Abnormal284169
Post prandialNormal2212340.018*
Abnormal395796

*Significant (P<0.05). Chi-square test used

Table 2

Correlation of 2D echocardiographic findings with blood sugar levels

Blood sugarValue2D EchoTotal P

NormalAbnormal
RandomNormal3321540.005*
Abnormal274976
FastingNormal3823610.001*
Abnormal224769
Post prandialNormal2113340.045*
Abnormal395796

*Significant (P<0.05) Chi-square test used

Correlation of ECG findings with blood sugar levels *Significant (P<0.05). Chi-square test used Correlation of 2D echocardiographic findings with blood sugar levels *Significant (P<0.05) Chi-square test used About 46.9% of total cases had normal ECG findings, whereas 53.1% of total cases had abnormal findings. Among patients with abnormal ECG, 17.7% of cases had ST-T changes/T-Inversion, 8.5% of cases had bundle branch block, 3.8% of cases had q waves, 22.3% of cases had left axis deviation, and 20% of cases had resting sinus tachycardia. About 46.2% of total cases had normal findings and 53.8% of total cases had abnormal findings on 2D Echo. Among patients with abnormal 2D echo, 48.5% of cases had diastolic dysfunction, 46.9% had left ventricular hypertrophy or LVH, 11.5% systolic dysfunction, 13.8% valvular dysfunction, and 1.5% regional wall motion abnormality. About 25 cases out of 65 having abnormal 2 D Echo had normal ECGs (38.5%) and 24 out of 69 (34.8%) having abnormal ECGs had normal 2D Echo [Table 3].
Table 3

Correlation of electrocardiographic findings with 2D echocardiographic findings

ECG findings2D EchoTotal P

NormalAbnormal
Normal3625610.008*
Abnormal244569
Total6070130

*Significant (P<0.05) Chi-square test used

Correlation of electrocardiographic findings with 2D echocardiographic findings *Significant (P<0.05) Chi-square test used

Discussion

In our study, 2 D Echo abnormalities showed significant correlation with age similar to the study by Khaire et al.[5] where there is a linear progression of 2 D echocardiographic abnormality like diastolic dysfunction with the increasing age. About 53.1% of patients had abnormal electrocardiographic findings in our study. In the above study, 40% patients had ECG abnormalities. ECG abnormalities showed significant correlation with random and postprandial blood sugar, though correlation with fasting blood sugar was not significant. It was also reflected in the Diabetes Intervention Study[6] involving 1139 newly diagnosed Type 2 diabetic patients of 30–55 years of age. In this study, 2 hours’ postprandial blood glucose was associated with higher rates of myocardial infarction and mortality. This correlation was not seen with fasting blood sugar. In another multivariate regression analysis, post prandial but not fasting blood glucose was an independent predictor of total mortality.[7] However, 2D Echocardiographic abnormalities showed significant correlation with random, fasting, and postprandial blood sugar similar to a study by Hasan et al.[8] where patients with 2D echocardiographic abnormalities like left ventricular diastolic dysfunction had higher levels of fasting blood glucose and postprandial glucose in comparison to those with preserved left ventricular diastolic function. Older the age group, more was the diastolic dysfunction in that study. Similar results were found by Patil et al.[9] who concluded that diastolic dysfunction was significantly higher in more than 45 years age group as compared to less than 45 years (p value < 0.05). In a study by Roy et al.,[10] poor glycemic status, that is, high fasting blood sugar (FBS) (p = 0.007) and postprandial blood sugar (PPBS) (p = 0.001), was associated with left ventricular systolic dysfunction on 2D echocardiography. In this study among 226 patients (151 males, 75 females), it was seen in 29.2% patients, but in our study only 11.5% had systolic dysfunction. In our study, 46.9% had Left Ventricular Hypertrophy or LVH. Valensi, in an African diabetic population, found LVH in 33.6% and hypokinesia in 6.1% of study population.[11] The patients he included had one or more CVD risk factors and he used rest echocardiography and myocardial scintigraphy for assessment. In a study by Muddu et al.[12] prevalence of LVH was up to 19.3% and regional wall motion abnormalities were present among 4.0% of the patients as compared to 1.5% in our study. The lower prevalence of LVH in the above study was probably because of maximum number of patients having duration of diabetes less than 2 months, while our study had higher number of patients with duration more than 5 years. As compared to previous reports, left ventricular diastolic dysfunction (LVDD) is much more common in subjects with well-controlled type 2 diabetes who have no clinically detectable heart disease.[13] The high prevalence of this phenomenon suggests that screening for LVDD in type 2 diabetes should be done regularly.[1314] More the age more will be the 2D echocardiographic abnormalities. So, it is very important to screen for cardiovascular abnormalities through 2D echocardiography as the person grows older. 2D echocardiography is cost-effective and non-invasive diagnostic technique. It provides useful information regarding cardiac hemodynamic and function.[15]

Conclusions

Type 2 diabetic patients seen by primary physicians may have silent cardiovascular disease of long duration. Hence, these patients in spite of having no cardiovascular symptoms should be screened for cardiovascular abnormalities, so that early interventions can be done to prevent further progression to symptomatic cardiovascular abnormalities. Blood sugar control, post prandial more than fasting, is of primary importance to prevent cardiovascular abnormalities and prevent cardiovascular morbidity and mortality. There is a significant number of people having normal ECG but abnormal 2D Echo and vice versa, so not only ECG but also 2D Echo should be added to it to predict cardiovascular risk in type 2 diabetic patients without cardiovascular symptoms.

Take home message

ECG and 2D Echo are two modalities of investigations which are non-invasive and easily available for family physicians and primary care providers and they should make full use of these cost-effective modalities for diagnosis of cardiovascular disease in asymptomatic diabetic patients.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  11 in total

1.  IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030.

Authors:  David R Whiting; Leonor Guariguata; Clara Weil; Jonathan Shaw
Journal:  Diabetes Res Clin Pract       Date:  2011-11-12       Impact factor: 5.602

2.  Prevalence, types and factors associated with echocardiographic abnormalities among newly diagnosed diabetic patients at Mulago Hospital.

Authors:  Martin Muddu; Edrisa Mutebi; Charles Mondo
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

3.  Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up.

Authors:  M Hanefeld; S Fischer; U Julius; J Schulze; U Schwanebeck; H Schmechel; H J Ziegelasch; J Lindner
Journal:  Diabetologia       Date:  1996-12       Impact factor: 10.122

Review 4.  Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

Authors:  E Bonora; M Muggeo
Journal:  Diabetologia       Date:  2001-12       Impact factor: 10.122

5.  The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study.

Authors:  Giacomo Faden; Giorgio Faganello; Stefania De Feo; Nicola Berlinghieri; Luigi Tarantini; Andrea Di Lenarda; Pompilio Faggiano; Giovanni Cioffi
Journal:  Diabetes Res Clin Pract       Date:  2013-07-23       Impact factor: 5.602

Review 6.  Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity.

Authors:  Guanghong Jia; Michael A Hill; James R Sowers
Journal:  Circ Res       Date:  2018-02-16       Impact factor: 17.367

7.  Transthoracic echocardiographic abnormalities in asymptomatic diabetic patients: association with microalbuminuria and silent coronary artery disease.

Authors:  M T Nguyen; E Cosson; P Valensi; P Poignard; A Nitenberg; I Pham
Journal:  Diabetes Metab       Date:  2011-03-12       Impact factor: 6.041

8.  Diastolic dysfunction in asymptomatic type 2 diabetes mellitus with normal systolic function.

Authors:  Virendra C Patil; Harsha V Patil; Kuldeep B Shah; Jay D Vasani; Pruthvi Shetty
Journal:  J Cardiovasc Dis Res       Date:  2011-10

9.  Know the signs and symptoms of diabetes.

Authors:  A Ramachandran
Journal:  Indian J Med Res       Date:  2014-11       Impact factor: 2.375

10.  Systolic dysfunction in asymptomatic type 2 diabetic patients, a harbinger of microvascular complications: A cross-sectional study from North India.

Authors:  Shankar Roy; Ravi Kant; Barun Kumar; Meenakshi Khapre; Mukesh Bairwa
Journal:  Diab Vasc Dis Res       Date:  2020 Jul-Aug       Impact factor: 3.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.